MIRO2 Protein

📖 Wiki Page

protein1124 wordssynced 2026-04-02

MIRO2 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MIRO2 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Mitochondrial Rho GTPase 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RHOT2</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>MIRO2, ARHI2, C16orf52</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q8IXI2](https://www.uniprot.org/uniprot/Q8IXI2)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>618 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~68 kDa</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>16p13.3</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondrial outer membrane</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">MIRO2 reducers</td>
<td>Small molecules promoting MIRO2 degradation to enhance mitophagy</td>
</tr>
<tr>
<td class="label">MIRO2 EF-hand modulators</td>
<td>Tuning calcium sensitivity of mitochondrial arrest</td>
</tr>
<tr>
<td class="label">Parkin activation</td>
<td>Enhance Parkin-mediated MIRO2 ubiquitination on damaged mitochondria</td>
</tr>
<tr>
<td class="label">TRAK1/2 modulation</td>
<td>Alter adaptor recruitment to shift transport dynamics</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>

...

MIRO2 Protein

Overview

MIRO2 (Mitochondrial Rho GTPase 2), also known as RHOT2, is a mitochondrial outer membrane GTPase encoded by the [RHOT2](/genes/rhot2) gene on chromosome 16p13.3. Together with its paralog [MIRO1](/proteins/miro1-protein) (RHOT1), MIRO2 is a central component of the mitochondrial transport machinery that regulates the movement, positioning, and dynamics of mitochondria within [neurons](/entities/neurons)[@aspenstrom2000]. MIRO2 functions as a calcium-sensitive adaptor linking mitochondria to motor protein complexes ([kinesin](/proteins/kinesin-protein) and [dynein](/mechanisms/dynein)) through the adaptor proteins Milton/TRAK1/TRAK2, enabling bidirectional transport along microtubule tracks[@schwarz2013]. In neurons, where mitochondria must travel enormous distances from the soma to distal synapses and axon terminals, MIRO-dependent transport is essential for maintaining local ATP production, calcium buffering, and synaptic function. Dysregulation of MIRO2-mediated mitochondrial transport and quality control is implicated in [Parkinson's disease](/diseases/parkinsons-disease), [Alzheimer's disease](/diseases/alzheimers-disease), and [Huntington's disease](/diseases/huntington-disease)[@wang2011][@panchal2022].

Protein Information

Structure

MIRO2 has a unique domain architecture among Rho-family GTPases, consisting of five domains arranged from N- to C-terminus[@aspenstrom2000][@schwarz2013]:

N-terminal GTPase domain (nGTPase): An atypical Rho GTPase domain that binds GTP/GDP but has low intrinsic GTPase activity. Mutations in this domain affect mitochondrial morphology.

First EF-hand domain (EF1): A calcium-binding helix-loop-helix motif that senses cytosolic Ca²⁺ levels.

Second EF-hand domain (EF2): A second Ca²⁺-binding motif that cooperates with EF1 to confer calcium sensitivity.

C-terminal GTPase domain (cGTPase): A second GTPase domain that regulates interactions with adaptor proteins.

C-terminal transmembrane anchor: A single transmembrane helix that inserts into the mitochondrial outer membrane.

The tandem EF-hand domains are the critical calcium-sensing elements. At resting cytosolic Ca²⁺ (~100 nM), MIRO2 maintains its interaction with the TRAK/Milton-motor complex, enabling mitochondrial transport. When local Ca²⁺ rises (>1 μM), Ca²⁺ binding to the EF-hands triggers a conformational change that disrupts the MIRO2-TRAK-kinesin complex, arresting mitochondrial movement[@schwarz2013][@saotome2008]. This calcium-dependent arrest mechanism positions mitochondria at sites of high energy demand and calcium buffering need, such as active synapses.

Normal Function

Mitochondrial Transport

MIRO2 is essential for long-range mitochondrial transport in neurons. It anchors the TRAK1/TRAK2 adaptor proteins to the mitochondrial surface, which in turn recruit kinesin-1 (KIF5) for anterograde transport toward axon terminals and cytoplasmic dynein for retrograde transport toward the soma[@aspenstrom2000][@schwarz2013]. The choice of transport direction is regulated by:

TRAK1: Preferentially recruits kinesin for anterograde axonal transport
TRAK2: Mediates both anterograde and retrograde transport, with a bias toward dendritic targeting

Calcium-Dependent Mitochondrial Arrest

At active synapses, glutamate receptor activation and voltage-gated calcium channel opening produce local Ca²⁺ transients. MIRO2's EF-hands sense these transients and arrest mitochondrial transport, accumulating mitochondria at sites where ATP production and Ca²⁺ buffering are most needed[@saotome2008]. This "activity-dependent mitochondrial docking" is critical for sustained synaptic transmission.

Mitochondrial Quality Control (Mitophagy)

MIRO2 intersects with the [PINK1](/proteins/pink1-protein)/[Parkin](/proteins/parkin-protein) mitophagy pathway. When mitochondria become depolarized, PINK1 accumulates on their outer membrane and recruits Parkin, an E3 ubiquitin ligase. Parkin ubiquitinates MIRO2, targeting it for proteasomal degradation. MIRO2 degradation disconnects damaged mitochondria from the transport machinery, quarantining them for autophagic clearance[@wang2011][@birsa2014]. This PINK1-Parkin-MIRO2 axis ensures that dysfunctional mitochondria are not transported to distant neuronal compartments.

Mitochondrial Dynamics

MIRO2 influences mitochondrial fission and fusion balance through interactions with [MFN1/MFN2](/proteins/mfn2-protein) (mitofusins) and [DRP1](/proteins/drp1-protein). MIRO2 stabilizes mitofusin complexes at mitochondrial contact sites, promoting fusion. Loss of MIRO2 shifts the balance toward excessive fission, generating fragmented mitochondria[@aspenstrom2000].

Role in Neurodegeneration

Parkinson's Disease

MIRO2 is directly linked to [Parkinson's disease](/diseases/parkinsons-disease) through the PINK1/Parkin pathway:

Failed MIRO degradation: In PD patients with [PINK1](/genes/pink1) or [PRKN](/genes/prkn) (Parkin) mutations, MIRO2 is not properly ubiquitinated and degraded on depolarized mitochondria. This allows damaged mitochondria to continue moving along axons, spreading dysfunction to distal compartments[@wang2011][@birsa2014].
LRRK2 interactions: The PD-associated kinase [LRRK2](/proteins/lrrk2-protein) phosphorylates MIRO2, promoting its removal from the mitochondrial surface. The G2019S LRRK2 mutation causes delayed MIRO2 removal, impairing mitophagy initiation[@hsieh2016].
Elevated MIRO2 in patient fibroblasts: Fibroblasts from idiopathic PD patients show abnormally high MIRO2 levels compared to controls, even in the absence of known genetic mutations, suggesting MIRO2 accumulation is a convergent PD mechanism[@panchal2022].
Therapeutic target: Reducing MIRO2 levels rescues mitophagy defects in PINK1- and Parkin-mutant cells, identifying MIRO2 as a druggable target[@birsa2014].

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), mitochondrial transport defects are an early pathological feature:

Amyloid-β disruption: [Amyloid-β](/proteins/amyloid-beta) oligomers impair axonal mitochondrial transport, partly through dysregulation of the MIRO-TRAK-kinesin complex
[Tau](/proteins/tau)-mediated transport blockade: Hyperphosphorylated [tau](/proteins/tau) obstructs microtubule-based transport, compounding MIRO2-dependent mitochondrial motility defects
Synaptic energy failure: Reduced mitochondrial delivery to synapses due to MIRO2/transport dysfunction contributes to the synaptic energy crisis characteristic of early AD[@panchal2022]

Huntington's Disease

Mutant [huntingtin](/proteins/huntingtin-protein) disrupts MIRO-dependent mitochondrial transport in striatal neurons, contributing to the selective vulnerability of medium spiny neurons in [Huntington's disease](/diseases/huntington-disease). [Huntingtin](/proteins/huntingtin) normally facilitates MIRO-TRAK interactions; polyglutamine expansion impairs this scaffolding function[@panchal2022].

Therapeutic Targeting

External Links

[UniProt: Q8IXI2](https://www.uniprot.org/uniprot/Q8IXI2)
[NCBI Gene: RHOT2](https://www.ncbi.nlm.nih.gov/gene/89941)
[GeneCards: RHOT2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RHOT2)

References

[Aspenstrom P, A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton (2000)](https://pubmed.ncbi.nlm.nih.gov/10620516/)

[Schwarz TL, Mitochondrial trafficking in neurons (2013)](https://pubmed.ncbi.nlm.nih.gov/23624858/)

[Wang X, Winter D, Bhatt DK, et al, PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility (2011)](https://pubmed.ncbi.nlm.nih.gov/22056988/)

[Panchal K, Bhatt DK, Miro, a Rho GTPase genetically interacts with Alzheimer's disease-associated genes (2022)](https://pubmed.ncbi.nlm.nih.gov/35650297/)

[Saotome M, Safiulina D, Bhatt DK, et al, Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase (2008)](https://pubmed.ncbi.nlm.nih.gov/18599742/)

[Birsa N, Norkett R, Wauer T, et al, Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase (2014)](https://pubmed.ncbi.nlm.nih.gov/24638119/)

[Hsieh CH, Shaltouki A, Goldman AE, et al, Functional impairment in Miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27580029/)

[Lopez-Domenech G, Covill-Cooke C, Ivankovic D, et al, Miro proteins coordinate microtubule- and actin-dependent mitochondrial transport and distribution (2018)](https://pubmed.ncbi.nlm.nih.gov/29551269/)

📖 View canonical wiki page →

MIRO2 Protein

MIRO2 Protein

Overview

MIRO2 Protein

Overview

Protein Information

Structure

Normal Function

Mitochondrial Transport

Calcium-Dependent Mitochondrial Arrest

Mitochondrial Quality Control (Mitophagy)

Mitochondrial Dynamics

Role in Neurodegeneration

Parkinson's Disease

Alzheimer's Disease

Huntington's Disease

Therapeutic Targeting

See Also

External Links

References